LianBio Operating Income Loss

Quick Answer

LianBio reported Operating Income Loss of -$125.35 million for the year ending 2022.

  • LianBio showed an increase of +35.9% in Operating Income Loss from 2021 to 2022.
  • This data is from LianBio's annual report (Form 10-K), filed with the SEC on March 28, 2023.
  • XBRL data for this metric is available from 2020 to 2022 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2020 to 2022), LianBio's Operating Income Loss has grown by 7.1%.
  • Historical annual values: Fiscal year 2022: -$125.35 million | Fiscal year 2021: -$195.57 million | Fiscal year 2020: -$134.87 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: